Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
about
Drug therapy for the prevention and treatment of bronchopulmonary dysplasiaVariation in the use of diuretic therapy for infants with bronchopulmonary dysplasiaSpironolactone effect on potassium supplementation in paediatric cardiac intensive care patients.Impact of Early Versus Late Diuretic Exposure on Metabolic Bone Disease and Growth in Premature Neonates.
P2860
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
@en
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
@nl
type
label
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
@en
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
@nl
prefLabel
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
@en
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
@nl
P1476
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone
@en
P2093
Jeffrey L Segar
P304
P356
10.1016/J.CLP.2011.12.007
P577
2011-12-29T00:00:00Z